Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results

We performed post-marketing surveillance to evaluate the safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART). In total, 356 CART sessions in 147 patients at 22 centers were performed. The most common primary disease was cancer (128 cases, 300 sessions). Mean amount of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Hanafusa, Norio, Isoai, Ayako, Ishihara, Tomoaki, Inoue, Tetsuya, Ishitani, Ken, Utsugisawa, Taiju, Yamaka, Toshihiko, Ito, Tetsuya, Sugiyama, Hiroshi, Arakawa, Atsushi, Yamada, Yosuke, Itano, Yasuo, Onodera, Hirokazu, Kobayashi, Ryosuke, Torii, Naoko, Numata, Toyoko, Kashiwabara, Taihei, Matsuno, Yoshihiro, Kato, Michio
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5433707/
https://ncbi.nlm.nih.gov/pubmed/28510606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0177303
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky